Zoetis Inc (NYSE:ZTS)
$ 169.04 0.91 (0.54%) Market Cap: 77.13 Bil Enterprise Value: 81.93 Bil PE Ratio: 32.57 PB Ratio: 15.27 GF Score: 96/100

Zoetis Inc at Bank of America Merrill Lynch Global Healthcare Conference Transcript

Sep 19, 2019 / 03:10PM GMT
Release Date Price: $124.27 (+0.84%)
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate

Thank you for joining us for our next session. My name is Mike Ryskin. I'm based in New York on the life science tools and diagnostics team, and I also have the pleasure and honor of being a animal health analyst here at Bank of America Merrill Lynch.

Joining me for this session is Clint Lewis from Zoetis. Thank you so much for taking the time to come out here and be with us.

Questions & Answers

Michael Leonidovich Ryskin;Clinton A. Lewis
BofA Merrill Lynch, Research Division - Associate;Zoetis Inc. - EVP and Grp President of Intl. Ops., Comm. Devp.,

Just to start, maybe just to get the ball rolling a little bit. I would say, 2019 has been a very, very busy and eventful year for Zoetis and for the animal health industry, overall. So could you give us an update of where we are now and your thoughts on the market overall? And sort of some new -- some of the major events that have transpired in recent months, just for the background?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot